Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Mutations of the cyclin‐dependent kinase‐like 5 (<i>CDKL5</i>) gene cause severe neurodevelopmental disorders characterized by intractable epilepsy, intellectual disability, and autism. Multiple mouse models generated for mechanistic studies have exhibited phenotypes similar to some human pathological features, but none of the models has developed one of the major symptoms affecting CDKL5 deficiency disorder (CDD) patients: intractable recurrent seizures. As disrupted neuronal excitation/inhibition balance is closely associated with the activity of glutamatergic and γ‐aminobutyric acidergic (GABAergic) neurons, our aim was to study the effect of the loss of CDKL5 in different types of neurons on epilepsy. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Using the Cre‐LoxP system, we generated conditional knockout (cKO) mouse lines allowing CDKL5 deficiency in glutamatergic or GABAergic neurons. We employed noninvasive video recording and in vivo electrophysiological approaches to study seizure activity in these <i>Cdkl5</i> cKO mice. Furthermore, we conducted Timm staining to confirm a morphological alteration, mossy fiber sprouting, which occurs with limbic epilepsy in both human and mouse brains. Finally, we performed whole‐cell patch clamp in dentate granule cells to investigate cell‐intrinsic properties and synaptic excitatory activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We demonstrate that Emx1‐ or CamK2α‐derived <i>Cdkl5</i> cKO mice manifest high‐frequency spontaneous seizure activities recapitulating the epilepsy of CDD patients, which ultimately led to sudden death in mice. However, <i>Cdkl5</i> deficiency in GABAergic neurons does not generate such seizures. The seizures were accompanied by typical epileptic features including higher amplitude spikes for epileptiform discharges and abnormal hippocampal mossy fiber sprouting. We also found an increase in spontaneous and miniature excitatory postsynaptic current frequencies but no change in amplitudes in the dentate granule cells of Emx1‐cKO mice, indicating enhanced excitatory synaptic activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Significance</h3><p>Our study demonstrates that <i>Cdkl5</i> cKO mice, serving as an animal model to study recurrent spontaneous seizures, have potential value for the pathological study of CDD‐related seizures and for therapeutic innovation. </p></section>

Excitatory Cortical Neurons from CDKL5 Deficiency Disorder Patient-Derived Organoids Show Early Hyperexcitability Not Identified in Neurogenin2 Induced Neurons

Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids

Novel CDKL5 targets identified in human iPSC-derived neurons

Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy

CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures

Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: A Calcium Channelopathy?

Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain

Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases

Pathological Networks Involving Dysmorphic Neurons in Type II Focal Cortical Dysplasia

Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes

CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development

Neurophysiological and brain structural insights into cyclin-dependent kinase-like 5 deficiency disorder: Visual and auditory evoked potentials and MRI analysis

GABA/Glutamate neuron differentiation imbalance and increased AKT/mTOR signalling in CNTNAP2 cerebral organoids

CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy

CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment

Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies

Regulatory networks specifying cortical interneurons from human embryonic stem cells reveal roles for CHD2 in interneuron development

Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy

Neuronal Defects in a Human Cellular Model of 22q11.2 Deletion Syndrome.

Longitudinal, multidimensional, observational study of 15 patients with CDKL5 Deficiency Disorder

Deletions in the CDKL5 5′ untranslated region lead to CDKL5 deficiency disorder